BSE filing, NSE: GEETANJ. Summary written from the filing by ALFA Finder's alert engine.
Geetanjali Credit and Capital Ltd: key numbers
- Share price
- ₹19.93
- Market cap
- ₹8.81 Cr
- Revenue (annual)
- ₹0.09 Cr
- Net profit (annual)
- ₹0.02 Cr
- P/E (TTM)
- 52.3×Sector 19.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Geetanjali Credit and Capital Ltd
All →Geetanjali Credit and Capital Board Meeting Date
Geetanjali Credit and Capital will hold a board meeting on 29 October 2026 to consider unaudited financial results for the quarter ended 30 September 2026. The filing is a prior intimation and no results are attached.
Geetanjali Credit and Capital Annual General Meeting
Geetanjali Credit and Capital Ltd will hold an Extra-ordinary General Meeting on 06th November 2026 to appoint directors and increase the authorized share capital.
Geetanjali Credit and Capital Capital Structure Change
The Board approved an increase in the Company's authorized share capital from ₹5 Crore to ₹95 Crore. An EGM is scheduled for November 6, 2026, for approval.
Geetanjali Credit and Capital Board Meeting Date
Geetanjali Credit and Capital Limited scheduled a board meeting for October 13, 2026, to consider increasing authorized share capital and convening an Extra-ordinary General Meeting.
Geetanjali Credit and Capital Management Change
Geetanjali Credit and Capital Limited appointed Ms. Ritu Tiwari as an Additional Independent Director and accepted the resignation of Mr. Vishnuji Ravaji Thakor.
Geetanjali Credit and Capital Board Meeting Outcome
Geetanjali Credit and Capital Ltd appointed Mr. Shreedhar Vasant Godbole as Managing Director and CFO, while Mr. Avinash Verma resigned as Additional Executive Director.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.